drugset
Drugs / Cultivated Autologous Limbal Epithelial Cell
last change Mar 2023 re-read 3 minutes ago

Cultivated Autologous Limbal Epithelial Cell

also known as CALEC

Cell therapy

Developed for
limbal stem cell deficiency
Investigated by
Dana-Farber Cancer Institute · Massachusetts Eye and Ear Infirmary

Trials 1

today NCT02592330 · Ph 1/2
20172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT02592330 Aug 2016 → Mar 2023 limbal stem cell deficiency Massachusetts Eye and Ear Infirmary Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Cultivated Autologous Limbal Epithelial Cell “Cultivated Autologous Limbal Epithelial Cell (CALEC)” NCT02592330 ↗
Known as CALEC “Cultivated Autologous Limbal Epithelial Cell (CALEC)” NCT02592330 ↗
Modality Cell therapy “Cultivated Autologous Limbal Epithelial Cell (CALEC) therapy” NCT02592330 ↗